The global GLP-1 Receptor Agonist Market reached USD 13.46 Billion in 2022 and is projected to experience a rapid revenue CAGR of 6% throughout the forecast period. The significant drivers of this growth include the introduction of innovative GLP-1 receptor agonist formulations, increasing demand for these medications, and a rising prevalence of type 2 Diabetes.
@ https://www.reportsanddata.com..../report-detail/glp-1
Like
Comment
Share
